Robert Michael Dudley
Chief Executive Officer at TransCode Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: TransCode Therapeutics Inc., 3 years.
TransCode Therapeutics Inc.
Director · Chief Executive Officer
Chief executive roles
TransCode Therapeutics Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 28, 2023 | TransCode Therapeutics Inc. | Open-market purchase | +98,000 | $0.51 | $49,980 |
| Jun 21, 2023 | TransCode Therapeutics Inc. | Open-market purchase | +12,000 | $2.65 | $31,800 |
| Jun 20, 2023 | TransCode Therapeutics Inc. | Open-market purchase | +6,607 | $2.55 | $16,848 |
| Jun 9, 2023 | TransCode Therapeutics Inc. | Open-market purchase | +19,000 | $2.76 | $52,440 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.